Birchview Capital, LP

Source: SEC Form 13F · as of Mar 2026

Birchview Capital, LP holds 53 biotech & pharma companies tracked by BioSniper, totaling $113.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

53

Total value held

$113.9M

CompanySharesValue
BMYBRISTOL MYERS SQUIBB CO306,268$18.6M
CMPXCompass Therapeutics, Inc.1,465,867$7.8M
STOKStoke Therapeutics, Inc.210,000$6.8M
NTLAIntellia Therapeutics, Inc.445,400$5.7M
GPCRStructure Therapeutics Inc.100,000$4.8M
SLDBSolid Biosciences Inc.625,980$4.5M
PRTAPROTHENA CORP PUBLIC LTD CO449,019$4.4M
ACADACADIA PHARMACEUTICALS INC171,000$3.8M
PTGXProtagonist Therapeutics, Inc35,000$3.7M
NBIXNEUROCRINE BIOSCIENCES INC27,190$3.6M
OLMAOlema Pharmaceuticals, Inc.219,000$3.3M
RLMDRELMADA THERAPEUTICS, INC.409,387$2.8M
OCULOCULAR THERAPEUTIX, INC320,000$2.7M
UTHRUNITED THERAPEUTICS Corp4,500$2.7M
NKTRNEKTAR THERAPEUTICS31,000$2.2M
CLDXCelldex Therapeutics, Inc.70,095$2.2M
PHATPhathom Pharmaceuticals, Inc.195,000$2.2M
BCYCBICYCLE THERAPEUTICS PLC463,599$2.2M
CMPSCOMPASS Pathways plc375,000$2.1M
CYTKCYTOKINETICS INC30,000$2.0M
CORTCORCEPT THERAPEUTICS INC47,200$1.9M
VERAVera Therapeutics, Inc.44,000$1.8M
ALKSAlkermes plc.50,000$1.8M
QUREuniQure N.V.100,697$1.6M
ZBIOZenas BioPharma, Inc.70,000$1.4M
FHTXFoghorn Therapeutics Inc.281,730$1.3M
RAREUltragenyx Pharmaceutical Inc.62,000$1.3M
XENEXenon Pharmaceuticals Inc.21,000$1.2M
KALVKalVista Pharmaceuticals, Inc.57,000$1.1M
IMNMImmunome Inc.50,000$1.1M
AXSMAxsome Therapeutics, Inc.6,000$1.0M
BIIBBIOGEN INC.5,000$917K
TVTXTravere Therapeutics, Inc.29,200$868K
PHVSPharvaris N.V.29,847$843K
VSTMVerastem, Inc.150,000$795K
APGEApogee Therapeutics, Inc.9,000$758K
HALOHALOZYME THERAPEUTICS, INC.10,100$653K
BBIOBridgeBio Pharma, Inc.8,688$645K
APLSApellis Pharmaceuticals, Inc.14,000$563K
IDYAIDEAYA Biosciences, Inc.16,860$562K
RCUSArcus Biosciences, Inc.25,889$559K
RGNXREGENXBIO Inc.66,270$555K
RCKTRocket Pharmaceuticals Inc.127,025$455K
VRDNViridian Therapeutics, Inc.\DE20,100$393K
CSTLCastle Biosciences Inc.12,900$317K
CADLCandel Therapeutics, Inc.60,000$294K
VYGRVoyager Therapeutics, Inc.74,918$289K
CGEMCullinan Therapeutics, Inc.20,000$284K
GRCEGrace Therapeutics, Inc.50,000$232K
KYNBKYNTRA BIO INC.22,566$153K
QNRXQuoin Pharmaceuticals, Ltd.20,000$132K
ZNTLZentalis Pharmaceuticals, Inc.17,503$41K
GOSSGossamer Bio, Inc.18,176$6K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.